IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Tumor Diagnostik und Therapie

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on June 27, 2025

Impact Score

2024-2025

0.00

h-Index

2024-2025

 6

Rank

2024-2025

 29791

SJR

2024-2025

 0.102

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title Tumor Diagnostik und Therapie
Abbreviation Tumor Diagn. Ther.
Publication Type Journal
Subject Area, Categories, Scope Oncology (Q4)
h-index 6
Overall Rank/Ranking 29791
SCImago Journal Rank (SJR) 0.102
Impact Score 0.00
Publisher Georg Thieme Verlag
Country Germany
ISSN 0722219X, 14391279
Best Quartile Q4
Coverage History 1983-2025




About Tumor Diagnostik und Therapie


Tumor Diagnostik und Therapie is a journal covering the technologies/fields/categories related to Oncology (Q4). It is published by Georg Thieme Verlag. The overall rank of Tumor Diagnostik und Therapie is 29791. According to SCImago Journal Rank (SJR), this journal is ranked 0.102. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 6. The best quartile for this journal is Q4.

The ISSN of Tumor Diagnostik und Therapie journal is 0722219X, 14391279. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Tumor Diagnostik und Therapie is cited by a total of 4 articles during the last 3 years (Preceding 2024).


Tumor Diagnostik und Therapie Impact IF 2024-2025


The Impact IF 2024 of Tumor Diagnostik und Therapie is 0.00, which is computed in 2025 as per its definition. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Tumor Diagnostik und Therapie Impact IF 2025 Prediction


Impact IF 2024 of Tumor Diagnostik und Therapie is 0.00. If the same downward trend persists, Impact IF may fall in 2025 as well.


Impact IF Trend


Year wise Impact IF of Tumor Diagnostik und Therapie. Based on Scopus data.


Year Impact IF
2025/2026 Coming Soon
2024 0.00
2023 0.01
2022 0.01
2021 0.02
2020 0.02
2019 0.00
2018 0.00
2017 0.01
2016 0.03
2015 0.00
2014 0.00

Tumor Diagnostik und Therapie h-index


  Table Setting

Tumor Diagnostik und Therapie has an h-index of 6. It means 6 articles of this journal have more than 6 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Tumor Diagnostik und Therapie ISSN


The ISSN of Tumor Diagnostik und Therapie is 0722219X, 14391279. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Tumor Diagnostik und Therapie Rank and SCImago Journal Rank (SJR)


The overall rank of Tumor Diagnostik und Therapie is 29791. According to SCImago Journal Rank (SJR), this journal is ranked 0.102. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Tumor Diagnostik und Therapie by Year


Year SJR
2025/2026 Coming Soon
2024 0.102
2023 0.101
2022 0.101
2021 0.106
2020 0.106
2019 0.100
2018 0.100
2017 0.102
2016 0.102
2015 0.100
2014 0.100

Ranking of Tumor Diagnostik und Therapie by Year


Year Ranking
2025/2026 Coming Soon
2024 29791
2023 28545
2022 27385
2021 24890
2020 29519
2019 30056
2018 31485
2017 30010
2016 29829
2015 31786
2014 31208

Tumor Diagnostik und Therapie Publisher


Table Setting

Tumor Diagnostik und Therapie is published by Georg Thieme Verlag. It's publishing house is located in Germany. Coverage history of this journal is as following: 1983-2025. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Tumor Diagnostik und Therapie is Tumor Diagn. Ther.. This abbreviation ('Tumor Diagn. Ther.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Tumor Diagnostik und Therapie


If your research field is/are related to Oncology (Q4), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the Tumor Diagnostik und Therapie?

Tumor Diagnostik und Therapie latest impact IF is 0.00. It's evaluated in the year 2024. The highest and the lowest impact IF or impact score of this journal are 0.03 (2016) and 0.00 (2024), respectively, in the last 11 years. Moreover, its average IS is 0.01 in the previous 11 years.


What's the SCImago Journal Rank (SJR) of the Tumor Diagnostik und Therapie?

The Tumor Diagnostik und Therapie has an SJR (SCImago Journal Rank) of 0.102, according to the latest data. It is computed in the year 2025. In the past 11 years, this journal has recorded a range of SJR, with the highest being 0.106 in 2021 and the lowest being 0.100 in 2019. Furthermore, the average SJR of the Tumor Diagnostik und Therapie over the previous 11-year period stands at 0.01.


What's the latest h-index of the Tumor Diagnostik und Therapie?

The latest h-index of the Tumor Diagnostik und Therapie is 6.


Who's the publisher of the Tumor Diagnostik und Therapie?

The Tumor Diagnostik und Therapie is published by the Georg Thieme Verlag, with its country of publication being the Germany.


What's the current ranking of the Tumor Diagnostik und Therapie?

The Tumor Diagnostik und Therapie is currently ranked 29791 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 11 years, this journal has experienced varying rankings, reaching its highest position of 24890 in 2021 and its lowest position of 31786 in 2015.


What's the abbreviation or short name for the Tumor Diagnostik und Therapie?

The standard ISO4 abbreviation for the Tumor Diagnostik und Therapie is Tumor Diagn. Ther..


Is the "Tumor Diagnostik und Therapie" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

Tumor Diagnostik und Therapie is classified as a journal that the Georg Thieme Verlag publishes.


What's the scope or major areas of the Tumor Diagnostik und Therapie?

The Tumor Diagnostik und Therapie encompasses the following areas:

  • Oncology

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the Tumor Diagnostik und Therapie?

The Tumor Diagnostik und Therapie is assigned the following International Standard Serial Numbers (ISSN): 0722219X, 14391279.


What's the best quartile of the Tumor Diagnostik und Therapie?

The best quartile for the Tumor Diagnostik und Therapie is Q4 (2024).


What's the coverage history of the Tumor Diagnostik und Therapie?

The Tumor Diagnostik und Therapie coverage history can be summarized as follows: 1983-2025.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Journal of Field Archaeology journal 7683 Maney Publishing 48 1.85
Proceedings of the ASME Turbo Expo conference and proceedings 17577 54 0.00
Journal of Geriatric Physical Therapy journal 8686 Lippincott Williams and Wilkins Ltd. 53 1.55
Journal of Sociolinguistics journal 4415 Wiley-Blackwell Publishing Ltd 68 2.14
Transnational Corporations journal 13970 UNCTAD United Nations Conference on Trade and Development 30 1.63
Museum Management and Curatorship journal 10490 Routledge 43 2.06
Consulting engineer Barrington journal 24079 Cahners Pub. Co. 0 0.00
Metascience journal 24313 Springer Nature 3 0.00
Clinical Interventions in Aging journal 4023 Dove Medical Press Ltd. 114 3.68
Journal of Medical Toxicology journal 5436 Springer New York 64 1.71

Check complete list




Year wise Impact Score (IS) of Tumor Diagnostik und Therapie

Impact Score Table

Year Impact Score (IS)
2025/2026 Coming Soon
2024 0.00
2023 0.01
2022 0.01
2021 0.02
2020 0.02
2019 0.00
2018 0.00
2017 0.01
2016 0.03
2015 0.00
2014 0.00



Top Journals/Conferences in Oncology

Ca-A Cancer Journal for Clinicians
John Wiley and Sons Inc | United States

Nature Reviews Clinical Oncology
Nature Publishing Group | United Kingdom

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Annals of Oncology
Elsevier Ltd | United Kingdom

Cancer Cell
Cell Press | United States

Nature Cancer
Nature Research | United States

Lancet Oncology, The
Elsevier Ltd | United Kingdom

Journal of Clinical Oncology
Lippincott Williams and Wilkins | United States

Journal of Hematology and Oncology
BioMed Central Ltd | United Kingdom

Molecular Cancer
BioMed Central Ltd | United Kingdom

See All